REDDIT
Novo Nordisk Warns of 2026 Sales and Profit Decline as U.S. Pricing Pressure Mounts
Novo Nordisk forecasts **2026 adjusted sales and operating profit to fall 5%–13%**, as U.S. pricing pressure and competition offset continued GLP-1 volume growth.